aluates Reports

$ 0.0

Automative

Global Isovaleric Acidemia Treatment Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-12G13007

Global Isovaleric Acidemia Treatment Market Research Report 2023

BUY CHAPTERS

Global Isovaleric Acidemia Treatment Market Research Report 2025

Code: QYRE-Auto-12G13007

Report

April 2025

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Amgen Inc

Oncolys BioPharma

Targovax

Lokon Pharma

Vyriad

TILT Biotherapeutics

DNAtrix

Replimune Group Inc.

VCNBiosciences

Transgene SA

Isovaleric Acidemia Treatment Market Size

The global market for Isovaleric Acidemia Treatment was valued at US$ 664 million in the year 2024 and is projected to reach a revised size of US$ 967 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Isovaleric Acidemia Treatment Market

Isovaleric acidemia (IVA) is a rare metabolic disorder characterized by the body"s inability to properly break down the amino acid leucine, leading to the accumulation of isovaleric acid. Left untreated, IVA can result in severe health problems and even death. Treatment for IVA primarily involves dietary management, including a low-protein diet and the use of specialized medical formulas. The market for IVA treatment primarily consists of specialized medical foods, dietary supplements, and medications designed to help manage the condition.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Isovaleric Acidemia Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Isovaleric Acidemia Treatment.

The Isovaleric Acidemia Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Isovaleric Acidemia Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Isovaleric Acidemia Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Isovaleric Acidemia Treatment Market Report

Report Metric	Details
Report Name	Isovaleric Acidemia Treatment Market
Accounted market size in year	US$ 664 million
Forecasted market size in 2031	US$ 967 million
CAGR	5.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	L-Carnitine Supplements Glycine Supplements Others
Segment by Application	Hospital Personal Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Replimune Group Inc., Transgene SA, Oncolys BioPharma, Targovax, Lokon Pharma, Vyriad, TILT Biotherapeutics, VCNBiosciences, DNAtrix
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Isovaleric Acidemia Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Isovaleric Acidemia Treatment Market growing?

Ans: The Isovaleric Acidemia Treatment Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Isovaleric Acidemia Treatment Market size in 2031?

Ans: The Isovaleric Acidemia Treatment Market size in 2031 will be US$ 967 million.

Who are the main players in the Isovaleric Acidemia Treatment Market report?

Ans: The main players in the Isovaleric Acidemia Treatment Market are Amgen, Replimune Group Inc., Transgene SA, Oncolys BioPharma, Targovax, Lokon Pharma, Vyriad, TILT Biotherapeutics, VCNBiosciences, DNAtrix

What are the Application segmentation covered in the Isovaleric Acidemia Treatment Market report?

Ans: The Applications covered in the Isovaleric Acidemia Treatment Market report are Hospital, Personal, Other

What are the Type segmentation covered in the Isovaleric Acidemia Treatment Market report?

Ans: The Types covered in the Isovaleric Acidemia Treatment Market report are L-Carnitine Supplements, Glycine Supplements, Others

Recommended Reports

Rare Disease Treatments

Metabolic & Acid Disorders

General Treatment Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Isovaleric Acidemia Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 L-Carnitine Supplements

1.2.3 Glycine Supplements

1.2.4 Others

1.3 Market by Application

1.3.1 Global Isovaleric Acidemia Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Personal

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Isovaleric Acidemia Treatment Market Perspective (2020-2031)

2.2 Global Isovaleric Acidemia Treatment Growth Trends by Region

2.2.1 Global Isovaleric Acidemia Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Isovaleric Acidemia Treatment Historic Market Size by Region (2020-2025)

2.2.3 Isovaleric Acidemia Treatment Forecasted Market Size by Region (2026-2031)

2.3 Isovaleric Acidemia Treatment Market Dynamics

2.3.1 Isovaleric Acidemia Treatment Industry Trends

2.3.2 Isovaleric Acidemia Treatment Market Drivers

2.3.3 Isovaleric Acidemia Treatment Market Challenges

2.3.4 Isovaleric Acidemia Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Isovaleric Acidemia Treatment Players by Revenue

3.1.1 Global Top Isovaleric Acidemia Treatment Players by Revenue (2020-2025)

3.1.2 Global Isovaleric Acidemia Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Isovaleric Acidemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Isovaleric Acidemia Treatment Revenue

3.4 Global Isovaleric Acidemia Treatment Market Concentration Ratio

3.4.1 Global Isovaleric Acidemia Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Isovaleric Acidemia Treatment Revenue in 2024

3.5 Global Key Players of Isovaleric Acidemia Treatment Head office and Area Served

3.6 Global Key Players of Isovaleric Acidemia Treatment, Product and Application

3.7 Global Key Players of Isovaleric Acidemia Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Isovaleric Acidemia Treatment Breakdown Data by Type

4.1 Global Isovaleric Acidemia Treatment Historic Market Size by Type (2020-2025)

4.2 Global Isovaleric Acidemia Treatment Forecasted Market Size by Type (2026-2031)

5 Isovaleric Acidemia Treatment Breakdown Data by Application

5.1 Global Isovaleric Acidemia Treatment Historic Market Size by Application (2020-2025)

5.2 Global Isovaleric Acidemia Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Isovaleric Acidemia Treatment Market Size (2020-2031)

6.2 North America Isovaleric Acidemia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Isovaleric Acidemia Treatment Market Size by Country (2020-2025)

6.4 North America Isovaleric Acidemia Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Isovaleric Acidemia Treatment Market Size (2020-2031)

7.2 Europe Isovaleric Acidemia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Isovaleric Acidemia Treatment Market Size by Country (2020-2025)

7.4 Europe Isovaleric Acidemia Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Isovaleric Acidemia Treatment Market Size (2020-2031)

8.2 Asia-Pacific Isovaleric Acidemia Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Isovaleric Acidemia Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Isovaleric Acidemia Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Isovaleric Acidemia Treatment Market Size (2020-2031)

9.2 Latin America Isovaleric Acidemia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Isovaleric Acidemia Treatment Market Size by Country (2020-2025)

9.4 Latin America Isovaleric Acidemia Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Isovaleric Acidemia Treatment Market Size (2020-2031)

10.2 Middle East & Africa Isovaleric Acidemia Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Isovaleric Acidemia Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Isovaleric Acidemia Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Details

11.1.2 Amgen Business Overview

11.1.3 Amgen Isovaleric Acidemia Treatment Introduction

11.1.4 Amgen Revenue in Isovaleric Acidemia Treatment Business (2020-2025)

11.1.5 Amgen Recent Development

11.2 Replimune Group Inc.

11.2.1 Replimune Group Inc. Company Details

11.2.2 Replimune Group Inc. Business Overview

11.2.3 Replimune Group Inc. Isovaleric Acidemia Treatment Introduction

11.2.4 Replimune Group Inc. Revenue in Isovaleric Acidemia Treatment Business (2020-2025)

11.2.5 Replimune Group Inc. Recent Development

11.3 Transgene SA

11.3.1 Transgene SA Company Details

11.3.2 Transgene SA Business Overview

11.3.3 Transgene SA Isovaleric Acidemia Treatment Introduction

11.3.4 Transgene SA Revenue in Isovaleric Acidemia Treatment Business (2020-2025)

11.3.5 Transgene SA Recent Development

11.4 Oncolys BioPharma

11.4.1 Oncolys BioPharma Company Details

11.4.2 Oncolys BioPharma Business Overview

11.4.3 Oncolys BioPharma Isovaleric Acidemia Treatment Introduction

11.4.4 Oncolys BioPharma Revenue in Isovaleric Acidemia Treatment Business (2020-2025)

11.4.5 Oncolys BioPharma Recent Development

11.5 Targovax

11.5.1 Targovax Company Details

11.5.2 Targovax Business Overview

11.5.3 Targovax Isovaleric Acidemia Treatment Introduction

11.5.4 Targovax Revenue in Isovaleric Acidemia Treatment Business (2020-2025)

11.5.5 Targovax Recent Development

11.6 Lokon Pharma

11.6.1 Lokon Pharma Company Details

11.6.2 Lokon Pharma Business Overview

11.6.3 Lokon Pharma Isovaleric Acidemia Treatment Introduction

11.6.4 Lokon Pharma Revenue in Isovaleric Acidemia Treatment Business (2020-2025)

11.6.5 Lokon Pharma Recent Development

11.7 Vyriad

11.7.1 Vyriad Company Details

11.7.2 Vyriad Business Overview

11.7.3 Vyriad Isovaleric Acidemia Treatment Introduction

11.7.4 Vyriad Revenue in Isovaleric Acidemia Treatment Business (2020-2025)

11.7.5 Vyriad Recent Development

11.8 TILT Biotherapeutics

11.8.1 TILT Biotherapeutics Company Details

11.8.2 TILT Biotherapeutics Business Overview

11.8.3 TILT Biotherapeutics Isovaleric Acidemia Treatment Introduction

11.8.4 TILT Biotherapeutics Revenue in Isovaleric Acidemia Treatment Business (2020-2025)

11.8.5 TILT Biotherapeutics Recent Development

11.9 VCNBiosciences

11.9.1 VCNBiosciences Company Details

11.9.2 VCNBiosciences Business Overview

11.9.3 VCNBiosciences Isovaleric Acidemia Treatment Introduction

11.9.4 VCNBiosciences Revenue in Isovaleric Acidemia Treatment Business (2020-2025)

11.9.5 VCNBiosciences Recent Development

11.10 DNAtrix

11.10.1 DNAtrix Company Details

11.10.2 DNAtrix Business Overview

11.10.3 DNAtrix Isovaleric Acidemia Treatment Introduction

11.10.4 DNAtrix Revenue in Isovaleric Acidemia Treatment Business (2020-2025)

11.10.5 DNAtrix Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Amgen Inc

Oncolys BioPharma

Targovax

Lokon Pharma

Vyriad

TILT Biotherapeutics

DNAtrix

Replimune Group Inc.

VCNBiosciences

Transgene SA

List of Tables

Table 1. Global Isovaleric Acidemia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of L-Carnitine Supplements

Table 3. Key Players of Glycine Supplements

Table 4. Key Players of Others

Table 5. Global Isovaleric Acidemia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Isovaleric Acidemia Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Isovaleric Acidemia Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Isovaleric Acidemia Treatment Market Share by Region (2020-2025)

Table 9. Global Isovaleric Acidemia Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Isovaleric Acidemia Treatment Market Share by Region (2026-2031)

Table 11. Isovaleric Acidemia Treatment Market Trends

Table 12. Isovaleric Acidemia Treatment Market Drivers

Table 13. Isovaleric Acidemia Treatment Market Challenges

Table 14. Isovaleric Acidemia Treatment Market Restraints

Table 15. Global Isovaleric Acidemia Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Isovaleric Acidemia Treatment Market Share by Players (2020-2025)

Table 17. Global Top Isovaleric Acidemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isovaleric Acidemia Treatment as of 2024)

Table 18. Ranking of Global Top Isovaleric Acidemia Treatment Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Isovaleric Acidemia Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Isovaleric Acidemia Treatment, Headquarters and Area Served

Table 21. Global Key Players of Isovaleric Acidemia Treatment, Product and Application

Table 22. Global Key Players of Isovaleric Acidemia Treatment, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Isovaleric Acidemia Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Isovaleric Acidemia Treatment Revenue Market Share by Type (2020-2025)

Table 26. Global Isovaleric Acidemia Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Isovaleric Acidemia Treatment Revenue Market Share by Type (2026-2031)

Table 28. Global Isovaleric Acidemia Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Isovaleric Acidemia Treatment Revenue Market Share by Application (2020-2025)

Table 30. Global Isovaleric Acidemia Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Isovaleric Acidemia Treatment Revenue Market Share by Application (2026-2031)

Table 32. North America Isovaleric Acidemia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Isovaleric Acidemia Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Isovaleric Acidemia Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Isovaleric Acidemia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Isovaleric Acidemia Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Isovaleric Acidemia Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Isovaleric Acidemia Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Isovaleric Acidemia Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Isovaleric Acidemia Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Isovaleric Acidemia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Isovaleric Acidemia Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Isovaleric Acidemia Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Isovaleric Acidemia Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Isovaleric Acidemia Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Isovaleric Acidemia Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 47. Amgen Company Details

Table 48. Amgen Business Overview

Table 49. Amgen Isovaleric Acidemia Treatment Product

Table 50. Amgen Revenue in Isovaleric Acidemia Treatment Business (2020-2025) & (US$ Million)

Table 51. Amgen Recent Development

Table 52. Replimune Group Inc. Company Details

Table 53. Replimune Group Inc. Business Overview

Table 54. Replimune Group Inc. Isovaleric Acidemia Treatment Product

Table 55. Replimune Group Inc. Revenue in Isovaleric Acidemia Treatment Business (2020-2025) & (US$ Million)

Table 56. Replimune Group Inc. Recent Development

Table 57. Transgene SA Company Details

Table 58. Transgene SA Business Overview

Table 59. Transgene SA Isovaleric Acidemia Treatment Product

Table 60. Transgene SA Revenue in Isovaleric Acidemia Treatment Business (2020-2025) & (US$ Million)

Table 61. Transgene SA Recent Development

Table 62. Oncolys BioPharma Company Details

Table 63. Oncolys BioPharma Business Overview

Table 64. Oncolys BioPharma Isovaleric Acidemia Treatment Product

Table 65. Oncolys BioPharma Revenue in Isovaleric Acidemia Treatment Business (2020-2025) & (US$ Million)

Table 66. Oncolys BioPharma Recent Development

Table 67. Targovax Company Details

Table 68. Targovax Business Overview

Table 69. Targovax Isovaleric Acidemia Treatment Product

Table 70. Targovax Revenue in Isovaleric Acidemia Treatment Business (2020-2025) & (US$ Million)

Table 71. Targovax Recent Development

Table 72. Lokon Pharma Company Details

Table 73. Lokon Pharma Business Overview

Table 74. Lokon Pharma Isovaleric Acidemia Treatment Product

Table 75. Lokon Pharma Revenue in Isovaleric Acidemia Treatment Business (2020-2025) & (US$ Million)

Table 76. Lokon Pharma Recent Development

Table 77. Vyriad Company Details

Table 78. Vyriad Business Overview

Table 79. Vyriad Isovaleric Acidemia Treatment Product

Table 80. Vyriad Revenue in Isovaleric Acidemia Treatment Business (2020-2025) & (US$ Million)

Table 81. Vyriad Recent Development

Table 82. TILT Biotherapeutics Company Details

Table 83. TILT Biotherapeutics Business Overview

Table 84. TILT Biotherapeutics Isovaleric Acidemia Treatment Product

Table 85. TILT Biotherapeutics Revenue in Isovaleric Acidemia Treatment Business (2020-2025) & (US$ Million)

Table 86. TILT Biotherapeutics Recent Development

Table 87. VCNBiosciences Company Details

Table 88. VCNBiosciences Business Overview

Table 89. VCNBiosciences Isovaleric Acidemia Treatment Product

Table 90. VCNBiosciences Revenue in Isovaleric Acidemia Treatment Business (2020-2025) & (US$ Million)

Table 91. VCNBiosciences Recent Development

Table 92. DNAtrix Company Details

Table 93. DNAtrix Business Overview

Table 94. DNAtrix Isovaleric Acidemia Treatment Product

Table 95. DNAtrix Revenue in Isovaleric Acidemia Treatment Business (2020-2025) & (US$ Million)

Table 96. DNAtrix Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

Table 100. Authors List of This Report

List of Figures

Figure 1. Isovaleric Acidemia Treatment Picture

Figure 2. Global Isovaleric Acidemia Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Isovaleric Acidemia Treatment Market Share by Type: 2024 VS 2031

Figure 4. L-Carnitine Supplements Features

Figure 5. Glycine Supplements Features

Figure 6. Others Features

Figure 7. Global Isovaleric Acidemia Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Isovaleric Acidemia Treatment Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Personal Case Studies

Figure 11. Other Case Studies

Figure 12. Isovaleric Acidemia Treatment Report Years Considered

Figure 13. Global Isovaleric Acidemia Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Isovaleric Acidemia Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Isovaleric Acidemia Treatment Market Share by Region: 2024 VS 2031

Figure 16. Global Isovaleric Acidemia Treatment Market Share by Players in 2024

Figure 17. Global Top Isovaleric Acidemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isovaleric Acidemia Treatment as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Isovaleric Acidemia Treatment Revenue in 2024

Figure 19. North America Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Isovaleric Acidemia Treatment Market Share by Country (2020-2031)

Figure 21. United States Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Isovaleric Acidemia Treatment Market Share by Country (2020-2031)

Figure 25. Germany Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Isovaleric Acidemia Treatment Market Share by Region (2020-2031)

Figure 33. China Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Isovaleric Acidemia Treatment Market Share by Country (2020-2031)

Figure 41. Mexico Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Isovaleric Acidemia Treatment Market Share by Country (2020-2031)

Figure 45. Turkey Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Isovaleric Acidemia Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Amgen Revenue Growth Rate in Isovaleric Acidemia Treatment Business (2020-2025)

Figure 49. Replimune Group Inc. Revenue Growth Rate in Isovaleric Acidemia Treatment Business (2020-2025)

Figure 50. Transgene SA Revenue Growth Rate in Isovaleric Acidemia Treatment Business (2020-2025)

Figure 51. Oncolys BioPharma Revenue Growth Rate in Isovaleric Acidemia Treatment Business (2020-2025)

Figure 52. Targovax Revenue Growth Rate in Isovaleric Acidemia Treatment Business (2020-2025)

Figure 53. Lokon Pharma Revenue Growth Rate in Isovaleric Acidemia Treatment Business (2020-2025)

Figure 54. Vyriad Revenue Growth Rate in Isovaleric Acidemia Treatment Business (2020-2025)

Figure 55. TILT Biotherapeutics Revenue Growth Rate in Isovaleric Acidemia Treatment Business (2020-2025)

Figure 56. VCNBiosciences Revenue Growth Rate in Isovaleric Acidemia Treatment Business (2020-2025)

Figure 57. DNAtrix Revenue Growth Rate in Isovaleric Acidemia Treatment Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Argininemia Treatment Market Insights Forecast to 2030

Global Arginase Deficiency Treatment Market Insights Forecast to 2030

Global Alkaptonuria Therapeutics Market Research Report 2025

Global Arginase Deficiency Therapeutics Market Insights Forecast to 2030

Phenylketonuria Treatment Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Isovaleric Acid Market Research Report 2024

Global L Valine Market Research Report 2025

Global Argininemia Drugs Market Insights Forecast to 2030

Global Arginase Deficiency Drugs Market Insights Forecast to 2030

Global L Isoleucine Market Insights Forecast to 2030

Global Propionic Acidemia Treat Market Research Report 2025

Global Valine Market Research Report 2025

Global Phenylketonuria PKU Market Research Report 2025

Medical Foods for Inborn Errors of Metabolism Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Phenylketonuria Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Feed Grade Valine Market Research Report 2025

Amino Acid Metabolism Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Isoleucine Market Insights Forecast to 2030

Global Vitamin IV Therapy Product Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions